Welcome to our dedicated page for PUBLIC CO MANAGEMENT SEC filings (Ticker: PCMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PUBLIC CO MANAGEMENT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PUBLIC CO MANAGEMENT's regulatory disclosures and financial reporting.
PUBLIC COMPANY MANAGEMENT CORPORATION (PCMC) has a controlling shareholder, Repository Services LLC, which reports beneficial ownership of 23,946,307 common shares, equal to 69.84% of the outstanding stock, with sole voting and dispositive power. Repository Services LLC acquired the shares from prior stockholders using its capital contributions and working capital from third-party investors who only hold economic, not voting, interests in the securities.
The reporting holder states it acquired the stake to exercise control over PCMC and influence management, operations, capital structure and strategic direction. Potential actions include business combinations or reverse-merger transactions (including a proposed acquisition of Physicians Capital Management Corporation), changes to capitalization, influencing the board and senior management, and buying or selling additional shares, depending on conditions.
PUBLIC CO MANAGEMENT CORP (PCMC) has a new controlling shareholder. Repository Services LLC filed a Schedule 13D reporting beneficial ownership of 23,946,307 shares of PCMC common stock, equal to 70.3% of outstanding shares, giving it sole voting and dispositive power over this stake.
Repository Services LLC acquired the shares from prior stockholders using its own capital and funds contributed by third-party investors who hold only economic, not voting or dispositive, interests. It states that it holds the stake to exercise control over PCMC and influence management, operations, capital structure and strategic direction, and may pursue business combinations or reverse‑merger transactions, including a proposed acquisition of Physicians Capital Management Corporation, as well as possible future share purchases or sales.
PUBLIC CO MANAGEMENT CORP (PCMC) reports that REPOSITORY SERVICES LLC is a more-than-10% beneficial owner, filing an initial statement of ownership on Form 3. The reporting entity holds 23,946,307 shares of PCMC common stock directly, acquired from prior stockholders.
The shares were purchased using the reporting entity’s capital and working capital funded by third-party investors. Those investors have an economic interest in the securities but, according to the disclosure, do not have voting or dispositive power over the shares.
Public Company Management Corporation reports that it remains a non‑operating shell with no revenues for the three and nine months ended June 30, 2026 and a net loss of $115,690 for the nine‑month period, compared with a loss of $67,356 a year earlier. General and administrative expenses more than doubled year over year to $117,498, driven largely by higher professional fees.
Liquidity is very limited: cash was $6,692 and total assets were $6,692 at June 30, 2026, against current liabilities of $329,543, resulting in a working capital deficit of $322,851. The company carries a related‑party note payable to Specialty Capital Lenders LLC of $279,484, maturing December 31, 2026, after a February 2026 restructuring that reduced principal and eliminated previously accrued interest.
Auditors and management highlight substantial doubt about the company’s ability to continue as a going concern, and management concludes that disclosure controls and internal control over financial reporting are not effective. To address its status as a shell, the company has signed a Share Exchange Agreement to acquire Physicians Capital Management Corporation, a healthcare real estate platform. If completed, Physicians’ shareholders are expected to own about 80% of the combined company through 68,566,368 new common shares and 24,913,918 preferred shares, significantly diluting current holders.
Public Company Management Corporation (PCMC) entered into a Share Exchange Agreement to acquire all issued and outstanding shares of Physicians Capital Management Corporation in exchange for 68,566,368 shares of PCMC common stock and 24,913,918 shares of PCMC preferred stock.
Under the deal the Exchange Shares will represent approximately 80% of PCMC’s outstanding common stock on a fully diluted, as-converted basis immediately after closing. The transaction contemplates reconstituting PCMC’s board with a Physicians-designated majority, appointing Conrad Ivie as CEO, and shifting PCMC’s primary business to healthcare-focused real estate. Closing is subject to customary conditions and is expected in Q3 2026.
Public Company Management Corporation agreed to acquire Physicians Capital Management Corporation through a share exchange that will shift control and change its business focus. PCMC will issue 68,566,368 shares of common stock and 24,913,918 preferred shares, including 1,000,000 Series A Voting Preferred, 15,942,612 Series B‑1, and 7,971,306 Series B‑2, in exchange for all Physicians shares.
The exchange shares are expected to represent about 80% of PCMC’s common stock on a fully diluted, as‑converted basis after closing, leaving existing PCMC holders with about 20%. Closing is targeted for the third quarter of 2026, subject to customary conditions and effectiveness of a Form S‑4 registration statement.
After closing, PCMC plans to cease being a shell company and focus on healthcare real estate, owning and developing income‑producing medical offices and outpatient facilities under long‑term triple‑net leases. Conrad Ivie, MD, is expected to gain voting control through Series A preferred and become Chief Executive Officer, with a board majority designated by Physicians.
Public Company Management Corporation remains a non-operating shell focused on finding a business combination. For the three months ended March 31, 2026, it generated no revenue and recorded a net loss of $74,107; the six-month loss was $91,130. Operating expenses rose sharply year over year due mainly to higher professional fees for audits.
Cash fell from $234,405 at September 30, 2025 to $15,052 at March 31, 2026, leaving a working capital deficit of $298,291 and an accumulated deficit of $5,827,307. The company restructured a related-party promissory note, reducing principal from $350,000 to $279,484 and temporarily suspending interest accrual, but it still depends on related parties for funding.
Management and the auditors highlight substantial doubt about the company’s ability to continue as a going concern. Internal control over financial reporting and disclosure controls were concluded to be not effective. The company reports preliminary discussions by its majority shareholder that could lead to a change in control and a potential future business combination, although no specific transaction is in place.
Public Company Management Corporation amended its Articles of Incorporation to confirm its authorized capital and give the board more flexibility over preferred stock. The amendment restates Article 4 to authorize 500,000,000 shares of common stock and 50,000,000 shares of preferred stock, each with $0.001 par value.
The board now has “blank-check” authority to create one or more series of preferred stock and set their specific rights and preferences by board resolution and a Certificate of Designation filed under Nevada law. The amendment was approved by holders of a majority of the voting power on February 28, 2026 and became effective when filed with the Nevada Secretary of State on April 13, 2026.
Public Company Management Corporation approved an amendment to Article 4 to restate authorized capital at 550,000,000 shares: 500,000,000 Common Stock and 50,000,000 Preferred Stock. The Board is expressly authorized to create one or more classes or series of Preferred Stock with designations and rights fixed by the Board.
The Amendment was approved by written consent of stockholders holding 23,946,307 shares (approximately 70.3%) of the 34,276,816 shares outstanding as of the Record Date and will become effective upon filing a Certificate of Amendment with the Nevada Secretary of State, expected no earlier than 20 calendar days after mailing. The Company also disclosed a non-binding LOI to acquire Physicians Capital Management Corporation, contemplating former Physicians shareholders owning ~80% of PCMC post-closing, subject to due diligence and a Definitive Agreement.
Public Company Management Corporation is furnishing an Information Statement to notify holders of an approved amendment to Article 4 of its Articles of Incorporation to restate authorized capital at 550,000,000 shares.
The amendment, approved by the Board and by Written Consent of stockholders holding 70.3% of the voting power, increases authorized share capital to 500,000,000 shares of Common Stock and 50,000,000 shares of Preferred Stock, each with a par value of $0.001 per share, and expressly grants the Board authority to create one or more classes or series of Preferred Stock and fix their terms under Nevada law. The Amendment does not itself issue shares; actual issuances would require compliance with applicable law and any required approvals.
The Company reports 34,276,816 shares of Common Stock outstanding as of the Record Date (February 28, 2026). The Information Statement discloses a contemplated, non-binding LOI under which PCMC may acquire Physicians Capital Management Corporation; parties currently contemplate former Physicians shareholders would own approximately 80% of PCMC post-closing on a fully diluted, as-converted basis, subject to a Definitive Agreement, due diligence, approvals, and applicable tax treatment.